Kiniksa Pharmaceuticals (NASDAQ:KNSA) plans to discontinue development of its drug abiprubart for the treatment of Sjögren’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback